Viewing Study NCT06895928


Ignite Creation Date: 2025-12-26 @ 11:13 AM
Ignite Modification Date: 2026-01-01 @ 2:28 AM
Study NCT ID: NCT06895928
Status: RECRUITING
Last Update Posted: 2025-04-22
First Post: 2025-03-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Trial of SHR-A2102 With Other Antitumor Therapies in Advanced Solid Tumors
Sponsor: Shanghai Hengrui Pharmaceutical Co., Ltd.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: SHR-A2102-209
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators